Literature DB >> 11850817

Hepatocyte growth factor/scatter factor activates proliferation in melanoma cells through p38 MAPK, ATF-2 and cyclin D1.

Juan A Recio1, Glenn Merlino.   

Abstract

Members of the mitogen-activated protein kinase (MAPK) superfamily, including p38 kinase and SAPK/JNK, play a central role in mediating cellular response to environmental stress, growth factors and cytokines. Hepatocyte growth factor/scatter factor (HGF/SF) is a multifunctional cytokine capable of eliciting mitogenic, motogenic and morphogenetic activities in responsive cells, and has been implicated in tumor development and metastasis. Binding of HGF/SF to its tyrosine kinase receptor c-Met stimulates multiple signal transduction pathways, leading to the activation of numerous transcription factors. We here report that HGF/SF can induce cyclin D1 expression in mouse melanoma cells, and that this up-regulation is mediated in part by the activating transcription factor-2 (ATF-2). HGF/SF-mediated phosphorylation of ATF-2 was reduced in the presence of either the p38 kinase-specific inhibitor SB203580, a dominant negative p38 mutant, the SAPK/JNK inhibitor JNK-interacting protein-1 (JIP-1), or the phosphatidylinositol 3-kinase (PI3K)-specific inhibitor LY294002. Activation of p38 kinase by HGF/SF was partially blocked by the PI3K-specific inhibitor as well. The upstream kinases for p38, MKK3/6, did not become activated following HGF/SF exposure, and ATF-2 activation was undiminished by transient transfection of a dominant negative MKK6 mutant. However, transcriptional up-regulation of cyclin D1 by HGF/SF was partially inhibited by the p38 kinase-specific inhibitor, and cyclin D1 protein induction was partially blocked by a dominant negative ATF-2 mutant. Notably, the p38 kinase-specific inhibitor was able to block melanoma cell proliferation but not motility. We conclude that the ATF-2 transcription factor becomes activated by HGF/SF through p38 MAPK and SAPK/JNK. Moreover, the p38-ATF-2 pathway can help mediate proliferation signals in tumor cells through transcriptional activation of key cell cycle regulators.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11850817     DOI: 10.1038/sj.onc.1205150

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  57 in total

1.  Involvement of multiple signaling pathways in follicular lymphoma transformation: p38-mitogen-activated protein kinase as a target for therapy.

Authors:  Kojo S J Elenitoba-Johnson; Stephen D Jenson; Robert T Abbott; Robert A Palais; Sandra D Bohling; Zhaosheng Lin; Sheryl Tripp; Paul J Shami; Lai Y Wang; Robert W Coupland; Rena Buckstein; Bayardo Perez-Ordonez; Sherrie L Perkins; Ian D Dube; Megan S Lim
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-19       Impact factor: 11.205

2.  Genome-wide in silico identification of transcriptional regulators controlling the cell cycle in human cells.

Authors:  Ran Elkon; Chaim Linhart; Roded Sharan; Ron Shamir; Yosef Shiloh
Journal:  Genome Res       Date:  2003-05       Impact factor: 9.043

3.  Notch signaling is necessary to maintain quiescence in adult muscle stem cells.

Authors:  Christopher R R Bjornson; Tom H Cheung; Ling Liu; Pinky V Tripathi; Katherine M Steeper; Thomas A Rando
Journal:  Stem Cells       Date:  2012-02       Impact factor: 6.277

4.  The status of phosphorylated p38 in esophageal squamous cell carcinoma.

Authors:  Shu-Tao Zheng; Chuan-Shan Zhang; Xu Qin; Yue-Hua Gen; Tao Liu; Ilyar Sheyhidin; Xiao-Mei Lu
Journal:  Mol Biol Rep       Date:  2011-12-14       Impact factor: 2.316

5.  p38α regulates cytokine-induced IFNγ secretion via the Mnk1/eIF4E pathway in Th1 cells.

Authors:  María Salvador-Bernáldez; Sara B Mateus; Iván Del Barco Barrantes; Simon C Arthur; Carlos Martínez-A; Angel R Nebreda; Jesús M Salvador
Journal:  Immunol Cell Biol       Date:  2017-06-14       Impact factor: 5.126

6.  The Effect of Selective c-MET Inhibitor on Hepatocellular Carcinoma in the MET-Active, β-Catenin-Mutated Mouse Model.

Authors:  Na Zhan; Adeola Adebayo Michael; Kaiyuan Wu; Gang Zeng; Aaron Bell; Junyan Tao; Satdarshan P Monga
Journal:  Gene Expr       Date:  2018-02-06

7.  Conformational bias imposed by source microseeds results in structural ambiguity.

Authors:  Netanel Tzarum; David Engelberg; Oded Livnah
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2011-07-13

8.  ATF7 is stabilized during mitosis in a CDK1-dependent manner and contributes to cyclin D1 expression.

Authors:  Etienne Schaeffer; Marc Vigneron; Annie-Paule Sibler; Mustapha Oulad-Abdelghani; Bruno Chatton; Mariel Donzeau
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

9.  An ATF2-derived peptide sensitizes melanomas to apoptosis and inhibits their growth and metastasis.

Authors:  Anindita Bhoumik; Tian-Gui Huang; Vladimir Ivanov; Lisa Gangi; Rui F Qiao; Savio L C Woo; Shu-Hsia Chen; Ze'ev Ronai
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

10.  Methylthioadenosine (MTA) inhibits melanoma cell proliferation and in vivo tumor growth.

Authors:  Pedro Andreu-Pérez; Javier Hernandez-Losa; Teresa Moliné; Rosa Gil; Judit Grueso; Anna Pujol; Javier Cortés; Matias A Avila; Juan A Recio
Journal:  BMC Cancer       Date:  2010-06-08       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.